Science & Strategy at the World Orphan Drug Congress

 

Strategy, advocacy and partnering for the orphan drug industry

2-5 November 2020

Melia Sitges Hotel Resort, Barcelona, Spain

 

 
700+
Attendees
350+
Companies
200+
Speakers
80%
Decision Makers
2
Co-located events

Science & Strategy

 

➤  Case studies in successfully pushing a new therapy to clinical trials and obtaining funding

➤  Showcasing new technology to big pharma, VCs and funders

➤  Toolkits for collaborative drug development

➤  Building a new drug development framework to translate academic research into drug development

➤  How to involve patients into research & drug development

2019 KEY SPEAKERS

 

Marc Martinell , CEO , Minoryx Therapeutics

Marc Martinell | CEO | Minoryx Therapeutics » speaking at Orphan Drug Congress

Dr Raul Insa , Founder And Chief Executive Officer , SOM Biotech SL

Dr Raul Insa | Founder And Chief Executive Officer | SOM Biotech SL » speaking at Orphan Drug Congress

Andrea Sáez , Asabys Partners

Andrea Sáez |  | Asabys Partners » speaking at Orphan Drug Congress

Olaf Ritzeler , Director, Rare Diseases External Innovation / Global Business Development And Licensing , Sanofi

Olaf Ritzeler | Director, Rare Diseases External Innovation / Global Business Development And Licensing | Sanofi » speaking at Orphan Drug Congress

Diego Ardigo , R&D Rare Diseases Unit Head , CHIESI Farmaceutici Spa

Diego Ardigo | R&D Rare Diseases Unit Head | CHIESI Farmaceutici Spa » speaking at Orphan Drug Congress